Anonymous ID: 630fba July 29, 2023, 6:39 a.m. No.19261933   🗄️.is 🔗kun   >>1939

Neither of these work for anon anymore as of the past 72 hours.

https://iyoutubetomp4.com/en2/

https://twsaver.com/

any anon suggest a youtube to mp4 free downloader and one for twitter vids?

Thanks in advance

o7

Anonymous ID: 630fba July 29, 2023, 6:49 a.m. No.19261959   🗄️.is 🔗kun   >>1975 >>1997

Get off the X

standard tactical practice- hand to hand, armed combat, weather threat, wildlife threat, industrial threat, existential threat, etc

 

Get off the X.

 

nuff said.

Anonymous ID: 630fba July 29, 2023, 8:56 a.m. No.19262578   🗄️.is 🔗kun   >>2593 >>2597 >>2599 >>2610 >>2615 >>2617 >>2636 >>2643

How is it that GWP and the rest of the 'media' that lurks here fails to report that the mrna gene editing technology products licensed and distributed by moderna and Pfizer were ordered and contracted for by the US Government via DARPA in 2013? It was notabled yesterday FFS, and has been posted and known her for at least 1 year if not more.

 

It was the US GOVERNMENT. - the vax and the precursor bioweapon.

aka 'the calls are coming from INSIDE the HOUSE'

Anonymous ID: 630fba July 29, 2023, 9:01 a.m. No.19262597   🗄️.is 🔗kun   >>2599 >>2615 >>2636

>>19262578

>he mrna gene editing technology products licensed and distributed by moderna and Pfizer were ordered and contracted for by the US Government via DARPA in 2013

 

Moderna and Pfizer were contracted at lleast as early as 2013 to craft mrna gene-editing technology.

 

The US Military /US Govt is the culprit.

Either moderna and pfizer failed to deliver on their contractual product delivery obligations, or they built exactly to spec, on contract and on schedule.

 

Removing the Viral Threat: Two Months to Stop Pandemic X from Taking Hold (2017)

 

DARPA aims to develop an integrated end-to-end platform that uses nucleic acid sequences to halt the spread of viral infections in sixty days or less

 

Over the past several years, DARPA-funded researchers have pioneered RNA vaccine technology, a medical countermeasure against infectious diseases that uses coded genetic constructs to stimulate production of viral proteins in the body, which in turn can trigger a protective antibody response.As a follow-on effort, DARPA funded research into genetic constructs that can directly stimulate production of antibodies in the body.1,2 DARPA is now launching the Pandemic Prevention Platform (P3) program, aimed at developing that foundational work into an entire system capable of halting the spread of any viral disease outbreak before it can escalate to pandemic status. Such a capability would offer a stark contrast to the state of the art for developing and deploying traditional vaccines—a process that does not deliver treatments to patients until months, years, or even decades after a viral threat emerges.

 

“DARPA’s goal is to create a technology platform that can place a protective treatment into health providers’ hands within 60 days of a pathogen being identified, and have that treatment induce protection in patients within three days of administration. We need to be able to move at this speed considering how quickly outbreaks can get out of control,” said Matt Hepburn, the P3 Program Manager. “The technology needs to work on any viral disease, whether it’s one humans have faced before or not.”

 

Recent outbreaks of viral infectious diseases such as Zika, H1N1 influenza, and Ebola have cast into sharp relief the inability of the global health system to rapidly contain the spread of a disease using existing tools and procedures. State-of-the-art medical countermeasures typically take many months or even years to develop, produce, distribute, and administer. These solutions often arrive too late—if at all—and in quantities too small to respond to emerging threats. In contrast, the envisioned P3 platform would cut response time to weeks and stay within the window of relevance for containing an outbreak.

 

Key to this undertaking are nucleic-acid-based technologies—those that are centered on DNA and RNA—including some developed under DARPA’s Autonomous Diagnostics to Enable Prevention and Therapeutics (ADEPT) program. Using these tools, scientists can identify protective antibodies from recovering patients and then, through a biological version of reverse engineering, manufacture genetic constructs that, when delivered, can instruct an individual’s body to produce similar protective antibodies. Significant quantities of these nucleic acid “blueprints” can be rapidly manufactured compared to state-of-the-art antibody production methods.

 

https://www.darpa.mil/news-events/2017-02-06a

 

Army General to Co-Lead 'Operation Warp Speed' for COVID-19 Vaccine

 

https://www.defense.gov/News/News-Stories/Article/Article/2188680/army-general-to-co-lead-operation-warp-speed-for-covid-19-vaccine/

p1

Anonymous ID: 630fba July 29, 2023, 9:01 a.m. No.19262599   🗄️.is 🔗kun   >>2615 >>2636

>>19262578

>>19262597

 

 

Pfizer AND Moderna were contracted in 2013 to craft mrna technology

 

DARPA Awards Moderna Therapeutics A Grant For Up To $25 Million To Develop Messenger RNA Therapeutics™

Research to focus on antibody production for immune defense

Oct 02, 2013

https://www.prnewswire.com/news-releases/darpa-awards-moderna-therapeutics-a-grant-for-up-to-25-million-to-develop-messenger-rna-therapeutics-226115821.html

 

Moderna Therapeutics, the company pioneering messenger RNA therapeutics™, a revolutionary new treatment modality to enable the in vivo production of therapeutic proteins, announced today that the Defense Advanced Research Projects Agency (DARPA) has awarded the company up to $25 million to research and develop its messenger RNA therapeutics™ platform as a rapid and reliable way to make antibody-producing drugs to protect against a wide range of known and unknown emerging infectious diseases and engineered biological threats.

 

Messenger RNA therapeutics™ can be designed to tap directly into the body's natural processes to produce antibodies without exposing people to a weakened or inactivated virus or pathogen, as is the case with the vaccine approaches currently being tested.

 

Pfizer Awarded DARPA Biodefense Contract– DoD Daily Contracts

Dec 4, 2013

https://news.clearancejobs.com/2013/12/04/pfizer-awarded-darpa-biodefense-contract-dod-daily-contracts/

 

Pfizer, Inc., has been awarded a $7,670,632 technology investment agreement. Pfizer shall perform a research and development program designed to develop a technology platform to identify and subsequently induce the production of protective antibodies to an emerging pathogen directly in an infected or exposed individual.

 

2 of 2

Anonymous ID: 630fba July 29, 2023, 9:04 a.m. No.19262617   🗄️.is 🔗kun   >>2636 >>2683

>>19262578

>It was the US GOVERNMENT. - the vax and the precursor bioweapon.

 

DARPA aka US DOD/ US Govt as well.

 

Just like the MRNA tech.

 

DARPA Denies Funding Wuhan Institute of Virology Amid Alleged Document Leak

https://www.newsweek.com/darpa-denies-funding-defuse-wuhan-institute-virology-proposal-leak-drastic-1631512

The Wuhan scientists were listed as partners on a funding proposal the environmental health nonprofit EcoHealth Alliance made to the U.S. government's Defense Advanced Research Projects Agency (DARPA)

 

Leaked Grant Proposal Confirms Chinese and American Scientists Planned to Create Novel Coronavirus

https://news.yahoo.com/leaked-grant-proposal-confirms-chinese-135452549.html

The grant proposal, obtained by the analysis group DRASTIC last month, was submitted to the U.S. Defense Advanced Research Projects Agency (DARPA) in 2018 by the EcoHealth Alliance, an American research non-profit that planned to collaborate with Chinese scientists at the Wuhan Institute of Virology to create a new virus using the funding.

 

“We will compile sequence/RNAseq data from a panel of closely related strains and compare full length genomes, scanning for unique SNPs representing sequencing errors,” the application states. “Consensus candidate genomes will be synthesised commercially using established techniques and genome-length RNA and electroporation to recover recombinant viruses.”

 

The Lab-Leak Debate Just Got Even Messier

https://www.theatlantic.com/science/archive/2021/09/lab-leak-pandemic-origins-even-messier/620209/

The latest piece of evidence came out this week in the form of a set of murkily sourced PDFs, with their images a bit askew. The main one purports to be an unfunded research grant proposal from Peter Daszak, the president of the EcoHealth Alliance, a global nonprofit focused on emerging infectious diseases, that was allegedly submitted to [b]DARPA[/b] in early 2018

 

Wuhan Lab Wanted to Genetically Enhance Bat Viruses to Study Human Risks, Documents Show

https://www.newsweek.com/wuhan-lab-wanted-genetically-enhance-bat-viruses-study-human-risks-documents-show-1631784

In a Monday post on DRASTIC Research's website, the group said documents shared by an unnamed whistleblower showed the EcoHealth Alliance "collaborated" with the Wuhan Institute of Virology to "carry out advanced and dangerous human pathogenicity Bat Coronavirus research" through a grant proposal EcoHealth Alliance filed with DARPA.

 

DARPA is a research agency within the U.S. Department of Defense which aims to "preserve military readiness by protecting against the infectious disease threat" through its PREEMPT program.

Anonymous ID: 630fba July 29, 2023, 9:11 a.m. No.19262643   🗄️.is 🔗kun

>>19262578

>How is it that GWP and the rest of the 'media' that lurks here fails to report that the mrna gene editing technology products licensed and distributed by moderna and Pfizer were ordered and contracted for by the US Government via DARPA in 2013?

 

Because the MSM and DARPA are two complementary organs of the same

MILITARY INDUSTRIAL COMPLEX